Log In
BCIQ
Print this Print this
 

Neboglamine (CR2249) (formerly XY2401)

  Manage Alerts
Collapse Summary General Information
Company Rottapharm Biotech s.r.l.
DescriptionPositive allosteric enhancer of the NMDA receptor and a selective norepinephrine reuptake inhibitor
Molecular Target NMDA receptor ; Norepinephrine transporter
Mechanism of ActionNMDA receptor modulator; Norepinephrine reuptake inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today